Immunomedics
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -6.45 | -100% |
| P/S |
|
895.1 | 33.58 | 2565.54% |
|
|
| P/BV |
|
34.2 | 4.79 | 613.64% |
|
|
| P/FCF |
|
-95.18 | 60.06 | -258.48% |
|
|
| Ev/Ebitda |
|
-29.06 | -17.26 | 68.36% |
|
|
| Ev/S |
|
476.13 | 22.49 | 2017.43% |
|
|
| Ev/FCF |
|
-91.79 | 67.63 | -235.73% |
|
|
| E/P |
|
-0.0161 | 0.0168 | -195.59% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-653.62 | -12.31 | 5211.79% | -25458.83 | -97.43% |
| ROE |
|
-99.71 | 9.39 | -1161.72% |
|
|
| ROA |
|
-45.46 | 0.1519 | -30022.76% |
|
|
| ROIC |
|
-49.79 | 7.63 | -752.18% |
|
|
| ROS |
|
-795.51 | -25.64 | 3002.53% |
|
|
| ROCE |
|
0 | 15.19 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-1.04 | -3.68 | -71.79% | -0.962 | +7.88% |
| Nеt Debt/Ebitda |
|
2.68 | -4.07 | -166.01% |
|
|
| Debt/Ratio |
|
0.2526 | 0.199 | 26.9% |
|
|
| Debt/Equity |
|
0.4585 | 1.67 | -72.47% |
|
|
| Debt/Net Income |
|
-0.8527 | 10.34 | -108.24% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2331 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4916 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
537.5 | 76.2 | 605.38% | ||
| Growth impulse Ebitda in 5 years |
|
434.02 | 44.75 | 869.88% | ||
| Growth impulse Net Income in 5 years |
|
498.98 | -15.36 | -3348.57% | ||
| Growth impulse FCF in 5 years |
|
413.61 | -9.39 | -4504.79% | ||
| Growth impulse EPS in 5 years |
|
152.05 | -84.03 | -280.95% |
IP Score
3.98/10
